YORBA LINDA, CA (PRWEB)
October 13, 2022
Labroots, the leading science-based social networking website offering premier virtual events and interactive webinars, today announced the 8th event in its ongoing coronavirus virtual event series, since the inaugural launch in 2020. This educational forum brings together researchers from various disciplines, clinicians, epidemiologists and scientists from leading medical, industrial and academic institutions around the world to share the latest advances to address the prevention, treatment and management of COVID-19/SARS- CoV-2 and the challenges presented.
The preeminent meeting continues to achieve attendance milestones, offering a comprehensive program featuring distinguished speakers and innovators in healthcare today. The previous (seven) virtual events will remain on-demand for continued viewing of valuable and informative content. The next series of presentations will be posted online on October 19, 2022 at 5:30 a.m. PDT, on general topics covering the epidemiology of COVD-19 – previous, current and future trends, variants and how the virus is changing, global preparedness, testing , research, and diagnostics, vaccines, and future vaccines, and lessons learned via live video webcasts, including keynote sessions (with live Q&As), industry-sponsored presentations, and discussions at demand available for immediate viewing.
To start the day, Dr. Adolfo Garcia-Sastre, Professor in the Departments of Microbiology and Medicine at the Tisch Cancer Center Icahn School of Medicine at Mount Sinai, will deliver a keynote address titled “A COVID-19 vaccine based on the virus of Newcastle disease”. In his keynote address, Dr. Scott A. Rivkees, Professor of Practice and Vice Chair of the Department of Health Services, Policy, and Practice at Brown University School of Public Health, will explore the direct and indirect impact of the COVID-19 pandemic on children. The Future of COVID-19: Expectations and Lessons will be discussed by keynote speaker Dr. Ali H. Mokdad, Director of Strategy, Population Health, University of Washington; Director, Middle Eastern Initiatives Professor, Health Metrics Sciences Institute for Health Metrics and Evaluation, and Dr. Yvonne Maldonado, Senior Associate Dean for Faculty Development and Diversity, Taube Endowed Professor of Global Health and Infectious Diseases, Professor of Pediatrics and Epidemiology and Population Health, Chief, Division of Pediatric Infectious Diseases, Stanford University School of Medicine will share natural history, diagnosis and surveillance and lessons learned about SARS-CoV-2 and COVID-19 in its main presentation. Finally, Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, will discuss the progression towards recovery from post-acute sequelae of SARS infection. -CoV-2 (PASC): the NIH RECOVER Initiative in its keynote.
“Despite the success of current SARS-CoV-2 vaccines in significantly reducing the number of COVID-19-related hospitalizations, improved vaccines that provide increased protection against breakthrough infections are highly desirable,” said Dr Adolfo Garcia. -Sastre, Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai.
“Our children are our future and have been impacted in so many ways by the pandemic,” said Scott Rivkees, MD, professor of practice at the Brown School of Public Health. “In addition to understanding the direct effect of COVID-19 itself on the pediatric population, it is important to also recognize the impact the pandemic has had on families, pediatric education and practice, and how this impact will last well beyond the end of the pandemic I am grateful to the Labroots platform for providing a forum to discuss these important issues.
“We have known for a long time that people can suffer from persistent symptom complexes after an acute infectious disease, but we have not been able to discover its cause or design effective treatments,” commented Dr. Walter Koroshetz, Director from the National Institute of Neurological Disorders and Stroke. (NINDS), National Institutes of Health. “Now that COVID-19 has infected nearly 100 million Americans, post-viral syndrome, now called “Long COVID,” poses a major health and scientific challenge. The NIH RECOVER Initiative is designed as a comprehensive research program to identify the underlying biology and test potential treatments. It is a pleasure to discuss RECOVER on the Labroots platform.
In addition to the keynote presentations, other highlights of the event include a presentation sponsored by LGC Clinical Diagnostics titled “COVID-19 Testing: Results and Recommendations from the Coronavirus Standards Task Force,” with Q&A in direct. More informative lectures on detecting SARS-CoV-2 neutralizing antibodies with GenScript’s SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT), a Phase 1 trial of cyclosporine for hospitalized patients with COVID-19, sponsored by NanoString Technologies, and a Thermo Presentation sponsored by Fisher Scientific on influenza: an underestimated threat, and much more not to be missed!
Produced on Labroots’ robust platform while connecting to all desktop and mobile devices, the interactive environment provides a seamless educational experience for all participants. The interactive event consists of a lobby with leaderboard and gamification, an auditorium featuring live video webcasts with live attendee discussions during scheduled presentations, an exhibit hall to interact with sponsors and see their recent contributions from the field, a poster room to explore data and engage in live chat conversations, and featuring a poster contest to give your research a competitive edge, and finally a lounge networking to connect and collaborate with colleagues. By participating in this series of virtual events, it is possible to earn 1 PACE Continuing Education Credit per presentation.
To register for the event, click here. Use the #LRcoronavirus hashtag to follow the conversation and connect with other members of the global coronavirus research community! Follow @Labroots on Twitter and @LabrootsInc on Facebook to connect with our team and stay up to date on the latest trends in coronavirus research.
Labroots is the leading science social networking website and leading source for science news and leading virtual events and educational webinars and more. Advancing science through content sharing capabilities, Labroots is a powerful advocate for amplifying global networks and communities. Founded in 2008, Labroots focuses on digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay at the top of their field by earning continuing education credits on a wide range of topics through their participation in webinars and virtual events. Today, Labroots delivers more than ever with Chati, a flexible and highly scalable event platform that enables the creation of unique, effective and memorable virtual events.